Literature DB >> 12107759

The cytoprotective role of taurine in exercise-induced muscle injury.

R Dawson1, M Biasetti, S Messina, J Dominy.   

Abstract

Intense exercise is thought to increase oxidative stress and damage muscle tissue. Taurine is present in high concentration in skeletal muscle and may play a role in cellular defenses against free radical-mediated damage. The aim of this study was to determine if manipulating muscle levels of taurine would alter markers of free radical damage after exercise-induced injury. Adult male Sprague-Dawley rats were supplemented via the drinking water with either 3% (w/v) taurine (n = 10) or the competitive taurine transport inhibitor, beta-alanine (n = 10), for one month. Controls (n = 20) drank tap water containing 0.02% taurine and all rats were placed on a taurine free diet. All the rats except one group of sedentary controls (n = 10) were subjected to 90 minutes of downhill treadmill running. Markers of cellular injury and free radical damage were determined along with tissue amino acid content. The 3% taurine treatment raised plasma levels about 2-fold and 3% beta-alanine reduced plasma taurine levels about 50%. Taurine supplementation (TS) significantly increased plasma glutamate levels in exercised rats. Exercise reduced plasma methionine levels and taurine prevented its decline. Taurine supplementation increased muscle taurine content significantly in all muscles except the soleus. beta-alanine decreased muscle taurine content about 50% in all the muscles examined. Lipid peroxidation (TBARS) was significantly increased by exercise in the extensor digitorium longus (EDL) and gastrocnemius (GAST) muscles. Both taurine and beta-alanine completely blocked the increase in TBARs in the EDL, but had no effect in the GAST. Muscle content of the cytosolic enzyme, lactate dehydrogenase (LDH) was significantly decreased by exercise in the GAST muscle and this effect was attenuated by both taurine and beta-alanine. Muscle myeloperoxidase (MPO) activity was significantly elevated in the gastrocnemius muscle, but diet had no effect. MPO activity was significantly increased by exercise in the liver and both taurine and beta-alanine blocked this effect. There was no effect of either exercise or the diets on MPO activity in the lung or spleen. Running performance as assessed by a subjective rating scale was improved by taurine supplementation and there was a significant loss in body weight in the beta-alanine-treated rats 24 hours after exercise. In summary, taurine supplementation or taurine depletion had measurable cytoprotective actions to attenuate exercise-induced injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107759     DOI: 10.1007/s007260200017

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  36 in total

1.  Early metabolic changes measured by 1H MRS in healthy and dystrophic muscle after injury.

Authors:  Su Xu; Stephen J P Pratt; Espen E Spangenburg; Richard M Lovering
Journal:  J Appl Physiol (1985)       Date:  2012-06-28

2.  24-Week β-alanine ingestion does not affect muscle taurine or clinical blood parameters in healthy males.

Authors:  Bryan Saunders; Mariana Franchi; Luana Farias de Oliveira; Vinicius da Eira Silva; Rafael Pires da Silva; Vitor de Salles Painelli; Luiz Augusto Riani Costa; Craig Sale; Roger Charles Harris; Hamilton Roschel; Guilherme Giannini Artioli; Bruno Gualano
Journal:  Eur J Nutr       Date:  2018-12-14       Impact factor: 5.614

3.  Effects of long-term taurine supplementation on age-related changes in skeletal muscle function of Sprague-Dawley rats.

Authors:  Yun Ma; Hitomi Maruta; Baojun Sun; Chengduo Wang; Chiaki Isono; Hiromi Yamashita
Journal:  Amino Acids       Date:  2021-01-04       Impact factor: 3.520

4.  A Systematic Risk Assessment and Meta-Analysis on the Use of Oral β-Alanine Supplementation.

Authors:  Eimear Dolan; Paul A Swinton; Vitor de Salles Painelli; Benedict Stephens Hemingway; Bruna Mazzolani; Fabiana Infante Smaira; Bryan Saunders; Guilherme G Artioli; Bruno Gualano
Journal:  Adv Nutr       Date:  2019-05-01       Impact factor: 8.701

5.  Taurine supplementation increases skeletal muscle force production and protects muscle function during and after high-frequency in vitro stimulation.

Authors:  Craig A Goodman; Deanna Horvath; Christos Stathis; Trevor Mori; Kevin Croft; Robyn M Murphy; Alan Hayes
Journal:  J Appl Physiol (1985)       Date:  2009-05-07

Review 6.  Neutrophil infiltration in exercise-injured skeletal muscle: how do we resolve the controversy?

Authors:  Barbara St Pierre Schneider; Peter M Tiidus
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

7.  Effect of taurine supplementation on the alterations in amino Acid content in skeletal muscle with exercise in rat.

Authors:  Keisuke Ishikura; Teruo Miyazaki; Song-Gyu Ra; Shoji Endo; Yusuke Nakamura; Takashi Matsuzaka; Shumpei Miyakawa; Hajime Ohmori
Journal:  J Sports Sci Med       Date:  2011-06-01       Impact factor: 2.988

Review 8.  The effect of muscle-damaging exercise on blood and skeletal muscle oxidative stress: magnitude and time-course considerations.

Authors:  Michalis G Nikolaidis; Athanasios Z Jamurtas; Vassilis Paschalis; Ioannis G Fatouros; Yiannis Koutedakis; Dimitris Kouretas
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

9.  Skeletal muscle metabolic responses to physical activity are muscle type specific in a rat model of chronic kidney disease.

Authors:  Keith G Avin; Meghan C Hughes; Neal X Chen; Shruthi Srinivasan; Kalisha D O'Neill; Andrew P Evan; Robert L Bacallao; Michael L Schulte; Ranjani N Moorthi; Debora L Gisch; Christopher G R Perry; Sharon M Moe; Thomas M O'Connell
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

Review 10.  Taurine and skeletal muscle disorders.

Authors:  Diana Conte Camerino; Domenico Tricarico; Sabata Pierno; Jean-François Desaphy; Antonella Liantonio; Michael Pusch; Rosa Burdi; Claudia Camerino; Bodvael Fraysse; Annamaria De Luca
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.